Essex Investment Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-52,907
Closed -$2.32M 323
2023
Q3
$2.32M Sell
52,907
-372
-0.7% -$18.1K 0.38% 89
2023
Q2
$2.63M Buy
53,279
+7,843
+17% +$361K 0.37% 98
2023
Q1
$1.88M Buy
+45,436
New +$1.89M 0.27% 120
2018
Q2
Sell
-130,754
Closed -$2.68M 399
2018
Q1
$2.68M Sell
130,754
-14,504
-10% -$262K 0.35% 83
2017
Q4
$2.65M Buy
145,258
+3,460
+2% +$68.5K 0.35% 80
2017
Q3
$3.17M Sell
141,798
-976
-0.7% -$22.1K 0.43% 52
2017
Q2
$3.46M Buy
142,774
+23,585
+20% +$501K 0.5% 46
2017
Q1
$2.28M Buy
119,189
+10,261
+9% +$180K 0.36% 71
2016
Q4
$2.13M Buy
108,928
+34,520
+46% +$626K 0.35% 73
2016
Q3
$1.18M Sell
74,408
-4,668
-6% -$71.8K 0.19% 130
2016
Q2
$1.12M Buy
79,076
+6,818
+9% +$104K 0.19% 125
2016
Q1
$1.22M Sell
72,258
-7,180
-9% -$126K 0.21% 107
2015
Q4
$1.78M Sell
79,438
-3,914
-5% -$80.7K 0.28% 83
2015
Q3
$1.83M Sell
83,352
-25,455
-23% -$636K 0.3% 75
2015
Q2
$2.68M Sell
108,807
-303
-0.3% -$6.77K 0.4% 69
2015
Q1
$2.24M Buy
109,110
+3,321
+3% +$64.3K 0.31% 85
2014
Q4
$2.11M Sell
105,789
-17,326
-14% -$297K 0.31% 86
2014
Q3
$1.81M Sell
123,115
-6,473
-5% -$103K 0.28% 99
2014
Q2
$2.38M Sell
129,588
-20,978
-14% -$349K 0.35% 81
2014
Q1
$2.83M Buy
150,566
+62,691
+71% +$1.28M 0.41% 64
2013
Q4
$1.64M Buy
87,875
+4,845
+6% +$70.4K 0.23% 129
2013
Q3
$912K Sell
83,030
-7,381
-8% -$72.8K 0.14% 187
2013
Q2
$859K Buy
+90,411
New +$788K 0.15% 167

Other funds holding ATRC

Essex Investment Management's ATRC Position: Q4 2023 in Review

Essex Investment Management sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 52,907 shares — an estimated $2.32M sold.

Essex Investment Management first reported a position in ATRC in Q2 2013 and held it in 23 quarters. The position peaked at $3.46M in Q2 2017. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Essex Investment Management reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
  • Essex Investment Management sold 52,907 AtriCure shares in Q4 2023, an estimated $2.32M.
  • Essex Investment Management first reported a position in AtriCure in Q2 2013 and held it in 23 quarters.
  • Essex Investment Management's AtriCure position peaked at $3.46M in Q2 2017.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Essex Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.